Prediction of microRNA target genes for diagnosis and prognosis of asthma development

BIO Web of Conferences, 2024

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1051/bioconf/202410002006
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Given the intricacy of diagnosis, there's an urgent necessity to establish objective and quantifiable biological indicators to enhance the accuracy of diagnosing asthma in its early stages. MicroRNAs emerge as promising candidates for asthma diagnosis. By leveraging the correlations between established target genes and microRNAs, a methodology for early asthma diagnosis can be formulated. A comprehensive database containing microRNAs and target genes implicated in asthma development has been compiled. The dynamics of microRNA interaction with target genes crucial for diagnosing and predicting the progression of asthma have been investigated. Specific microRNA binding sites with target genes involved in asthma development have been pinpointed. Using the DIANA-microTCDS program, features of microRNA interaction with target genes linked to asthma development have been analyzed. Notably, binding sites with significant occurrences have been identified in genes such as IL13, VEGFA, ADRB2, ALDH2, IL10, and DPP10. The conservativity of microRNA binding sites to mRNA genes has been demonstrated.